FCA
NVO

Fortis Capital Advisors’s Novo Nordisk NVO Stock Holding History

Fortis Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,279
Closed -$317K – 284
2024
Q4 		$317K Sell
2,279
-5,915
-72% -$640K 0.11% 144
2024
Q3 		$976K Buy
+8,194
New +$1.09M 0.33% 64
2023
Q2 		– Sell
-616
Closed -$49K – 446
2023
Q1 		$49K Sell
616
-8
-1% -$567 0.03% 286
2022
Q4 		$42.2K Buy
+624
New +$36.6K 0.03% 311

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Fortis Capital Advisors's NVO Position: Q1 2025 in Review

Fortis Capital Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,279 shares — an estimated $317K sold.

Fortis Capital Advisors first reported a position in NVO in Q4 2022 and held it in 4 quarters. The position peaked at $976K in Q3 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Fortis Capital Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Fortis Capital Advisors sold 2,279 Novo Nordisk shares in Q1 2025, an estimated $317K.
  • Fortis Capital Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 4 quarters.
  • Fortis Capital Advisors's Novo Nordisk position peaked at $976K in Q3 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Fortis Capital Advisors's 13F filing for Q1 2025, filed 20 May 2025.